Grunenthal Gmbh v. Teva Pharmaceuticals, Inc

Court

District Court, D. New Jersey (D.N.J.)
Official Court Website →

Assigned judge

Stanley R. Chesler · 3,374 cases in index

Docket number

2:24-cv-06104

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

None

Date filed

05/13/2024

Date terminated

11/22/2024

623 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Grunenthal Gmbh · 6 cases
• defendant · Teva Pharmaceuticals, Inc · 36 cases

Part of a Larger Litigation Pattern

This is one of 37 Patent - ANDA cases in our index naming Teva Pharmaceuticals, Inc — a possible mass-tort or coordinated-litigation cluster.

• Alkermes, Inc v. Teva Pharmaceuticals, Inc
  District Court, D. New JerseyFiled 08/15/2025
• Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals, Inc
  District Court, D. DelawareFiled 07/24/2025
• Pharmacosmos A/S v. Teva Pharmaceuticals, Inc
  District Court, D. New JerseyFiled 04/24/2025
• Axsome Therapeutics, Inc v. Teva Pharmaceuticals, Inc
  District Court, D. New JerseyFiled 05/28/2024
• Pfizer Inc v. Teva Pharmaceuticals, Inc
  District Court, D. DelawareFiled 05/23/2024
• Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals Inc
  District Court, D. DelawareFiled 04/04/2024

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Grunenthal Gmbh v. Teva Pharmaceuticals, Inc?

Grunenthal Gmbh v. Teva Pharmaceuticals, Inc is a federal patent - anda lawsuit filed on 05/13/2024 in the District Court, D. New Jersey. The case was terminated on 11/22/2024. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 2:24-cv-06104.

When was the case filed?

Grunenthal Gmbh v. Teva Pharmaceuticals, Inc was filed on 05/13/2024. It was terminated on 11/22/2024.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.